| Business Summary | | PolyMedica
Corporation
is
a
provider
of
direct-to-consumer
specialty
medical
products
and
services,
conducting
business
in
the
Chronic
Care,
Professional
Products
and
Consumer
Healthcare
markets.
The
Company
sells
diabetes
supplies
and
related
products
through
its
Chronic
Care
segment.
The
Company
provides
direct-to-consumer
prescription
respiratory
supplies
and
services
to
Medicare-eligible
seniors
suffering
from
chronic
obstructive
pulmonary
disease
(COPD)
and
also
markets,
manufactures
and
distributes
a
line
of
prescription
urological
and
suppository
products
through
its
Professional
Products
segment.
The
Company's
AZO
products
for
urinary
health
are
distributed
primarily
to
food
and
drug
retailers
and
mass
merchandisers
nationwide
through
its
Consumer
Healthcare
segment. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | PolyMedica
Corporation
is
a
nationwide
provider
of
direct-to-consumer
specialty
medical
products
and
services,
primarily
focused
on
the
diabetes
supply
and
consumer
healthcare
markets.
For
the
three
months
ended
6/30/01,
net
revenues
rose
25%
to
$63
million.
Net
income
before
accounting
change
increased
44%
to
$8.6
million.
Revenues
reflect
increased
sales
from
the
Chronic
Care
and
Professional
Products
segment.
Earnings
benefited
from
improved
margins. | More
from
Market Guide: Significant
Developments |
| | | | FY2001
Compensation | | Pay | Exer | |
| Steven Lee, 54 Chairman
and CEO | $1.6M | $1.6M | Arthur Siciliano, Ph.D., 58 Pres
and Pres of PolyMedica Pharmaceuticals (U.S.A.), Inc. | 1.1M | 590K | Stephen Farrell, 36 CFO | -- | -- | Eric Walters, 49 Exec.
VP and Clerk | 603K | 288K | John Reed Sr.
VP of Marketing and CMO | -- | -- | Dollar
amounts are as of 31-Mar-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|